Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan
· Delayed Price · Currency is TWD 16.25
-0.25 (-1.52%)
At close: Mar 9, 2026
Meribank Biotech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 136.2 | 165.09 | 399.46 | 85.16 | 192.15 | 51.4 | Upgrade
|
| Short-Term Investments | - | - | - | 122.7 | 94.1 | 45.9 | Upgrade
|
| Cash & Short-Term Investments | 136.2 | 165.09 | 399.46 | 207.86 | 286.25 | 97.3 | Upgrade
|
| Cash Growth | -17.84% | -58.67% | 92.18% | -27.39% | 194.21% | -39.10% | Upgrade
|
| Accounts Receivable | 166.19 | 158.22 | 128.63 | 146.97 | 147.53 | 136.06 | Upgrade
|
| Other Receivables | 6.19 | 8.82 | 6.5 | 5.47 | 1.63 | 0.14 | Upgrade
|
| Receivables | 172.38 | 167.04 | 135.13 | 152.44 | 149.17 | 136.2 | Upgrade
|
| Inventory | 9.67 | 11.24 | 6.91 | 8.45 | 3.6 | 2.94 | Upgrade
|
| Prepaid Expenses | 37.32 | 49.6 | 28.61 | 24.13 | 19.87 | 19.03 | Upgrade
|
| Other Current Assets | 0.37 | 0.34 | 0.09 | 0.02 | 0.11 | - | Upgrade
|
| Total Current Assets | 355.94 | 393.31 | 570.19 | 392.9 | 458.99 | 255.46 | Upgrade
|
| Property, Plant & Equipment | 461.4 | 479.46 | 162.06 | 178.19 | 190.76 | 210.04 | Upgrade
|
| Long-Term Investments | 57.53 | 59.57 | 59.56 | 25.22 | 44.45 | 18.89 | Upgrade
|
| Goodwill | 282.18 | 282.18 | 2.87 | - | - | - | Upgrade
|
| Other Intangible Assets | 565.21 | 584.09 | 31.69 | 10.22 | 1.09 | 1.92 | Upgrade
|
| Long-Term Deferred Tax Assets | 4.05 | 3.8 | 2.48 | - | - | - | Upgrade
|
| Other Long-Term Assets | 1,105 | 879.54 | 233.17 | 239.8 | 252.03 | 243.65 | Upgrade
|
| Total Assets | 2,831 | 2,682 | 1,062 | 846.33 | 947.32 | 729.97 | Upgrade
|
| Accounts Payable | 7.25 | 13.08 | 12.32 | 7.6 | 4.75 | 4.99 | Upgrade
|
| Accrued Expenses | 56.89 | 53.9 | 50.63 | 45.84 | 44.57 | 44.66 | Upgrade
|
| Current Portion of Long-Term Debt | 7.39 | 7.32 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 107.87 | 70.85 | 19.23 | 21.58 | 18.25 | 19.99 | Upgrade
|
| Current Unearned Revenue | 25.85 | 27.33 | 17.56 | 14.76 | 12.97 | 12.3 | Upgrade
|
| Other Current Liabilities | 20.22 | 59.76 | 27.17 | 19.28 | 15.34 | 16.96 | Upgrade
|
| Total Current Liabilities | 225.47 | 232.23 | 126.91 | 109.07 | 95.87 | 98.9 | Upgrade
|
| Long-Term Debt | 159.16 | 162.88 | - | - | - | - | Upgrade
|
| Long-Term Leases | 862.24 | 701.79 | 14.81 | 24.25 | 34.73 | 49.93 | Upgrade
|
| Long-Term Unearned Revenue | 267.39 | 258.41 | 245.7 | 236.52 | 228.14 | 195.56 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 96.67 | 99.83 | 1.38 | 0.65 | - | - | Upgrade
|
| Other Long-Term Liabilities | 9.36 | 9.42 | 2.02 | 2.05 | 2.53 | 2.95 | Upgrade
|
| Total Liabilities | 1,620 | 1,465 | 390.81 | 372.53 | 361.27 | 347.34 | Upgrade
|
| Common Stock | 879.76 | 879.76 | 709.76 | 627.76 | 627.76 | 526.71 | Upgrade
|
| Additional Paid-In Capital | 717.31 | 710.82 | 233.2 | 203.24 | 203.74 | 2.88 | Upgrade
|
| Retained Earnings | -392.29 | -373.23 | -272.2 | -350.09 | -247.58 | -148.39 | Upgrade
|
| Comprehensive Income & Other | -5.25 | -11.62 | -9.04 | -9.71 | 2.12 | 1.43 | Upgrade
|
| Total Common Equity | 1,200 | 1,206 | 661.73 | 471.2 | 586.05 | 382.64 | Upgrade
|
| Minority Interest | 11.37 | 11.65 | 9.46 | 2.59 | - | - | Upgrade
|
| Shareholders' Equity | 1,211 | 1,217 | 671.2 | 473.79 | 586.05 | 382.64 | Upgrade
|
| Total Liabilities & Equity | 2,831 | 2,682 | 1,062 | 846.33 | 947.32 | 729.97 | Upgrade
|
| Total Debt | 1,137 | 942.84 | 34.04 | 45.83 | 52.97 | 69.92 | Upgrade
|
| Net Cash (Debt) | -1,000 | -777.75 | 365.42 | 162.03 | 233.28 | 27.38 | Upgrade
|
| Net Cash Growth | - | - | 125.53% | -30.54% | 752.06% | -79.34% | Upgrade
|
| Net Cash Per Share | -11.37 | -9.78 | 5.81 | 2.58 | 3.87 | 0.52 | Upgrade
|
| Filing Date Shares Outstanding | 87.98 | 87.98 | 70.98 | 62.78 | 62.78 | 52.67 | Upgrade
|
| Total Common Shares Outstanding | 87.98 | 87.98 | 70.98 | 62.78 | 62.78 | 52.67 | Upgrade
|
| Working Capital | 130.47 | 161.08 | 443.27 | 283.83 | 363.12 | 156.56 | Upgrade
|
| Book Value Per Share | 13.63 | 13.71 | 9.32 | 7.51 | 9.34 | 7.26 | Upgrade
|
| Tangible Book Value | 352.14 | 339.46 | 627.17 | 460.98 | 584.96 | 380.72 | Upgrade
|
| Tangible Book Value Per Share | 4.00 | 3.86 | 8.84 | 7.34 | 9.32 | 7.23 | Upgrade
|
| Land | 214.7 | 214.7 | 41.08 | 41.08 | 41.08 | 41.08 | Upgrade
|
| Buildings | 107.62 | 107.62 | 53.84 | 53.23 | 52.95 | 52.95 | Upgrade
|
| Machinery | 101.02 | 96.57 | 76.56 | 61.45 | 62.83 | 61.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.